Deciphering the impact of genomic variation on function
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Our genomes influence nearly every aspect of human biology—from molecular and cellular functions to phenotypes in health and disease. Studying the differences in DNA sequence between individuals (genomic variation) could reveal previously unknown mechanisms of human biology, uncover the basis of genetic predispositions to diseases, and guide the development of new diagnostic tools and therapeutic agents. Yet, understanding how genomic variation alters genome function to influence phenotype has proved challenging. To unlock these insights, we need a systematic and comprehensive catalogue of genome function and the molecular and cellular effects of genomic variants. Towards this goal, the Impact of Genomic Variation on Function (IGVF) Consortium will combine approaches in single-cell mapping, genomic perturbations and predictive modelling to investigate the relationships among genomic variation, genome function and phenotypes. IGVF will create maps across hundreds of cell types and states describing how coding variants alter protein activity, how noncoding variants change the regulation of gene expression, and how such effects connect through gene-regulatory and protein-interaction networks. These experimental data, computational predictions and accompanying standards and pipelines will be integrated into an open resource that will catalyse community efforts to explore how our genomes influence biology and disease across populations. The Impact of Genomic Variation on Function Consortium is combining single-cell mapping, genomic perturbations and predictive modelling to investigate relationships between human genomic variation, genome function and phenotypes and will provide an open resource to the community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 1×
“IGVF will deliver variant effect maps and calibrated predictions that will ultimately substantially reduce the VUS burden in aetiological diagnosis of rare disease 124 .”
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
Self-citationThe mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
Self-citationSzklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1074 · Cited by 8,056
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
UniProt: the Universal Protein Knowledgebase in 2023
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., Bye-A-Jee, H., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1052 · Cited by 7,210
The GTEx Consortium atlas of genetic regulatory effects across human tissues
The GTEx Consortium, Aguet, F., Anand, S., Ardlie, K. G., Gabriel, S., Getz, G. A., Graubert, A., Hadley, K., Handsaker, R. E., Huang, K. H., et al. (2020) · Science · doi:10.1126/science.aaz1776 · Cited by 5,547
Self-citationCADD: predicting the deleteriousness of variants throughout the human genome
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1016 · Cited by 3,534
Self-citationClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning
Alipanahi, B., Delong, A., Weirauch, M. T., & Frey, B. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3300 · Cited by 2,873
An Expanded View of Complex Traits: From Polygenic to Omnigenic
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017) · Cell · doi:10.1016/j.cell.2017.05.038 · Cited by 2,851
Self-citationClinical use of current polygenic risk scores may exacerbate health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728 · cited 1×
“…shown, including 10x Multiome, SHARE-seq 70 and Parse Evercode 71 , MPRAs 52,56,57 , self-transcribing assay of RNA reporters 51 (STARR-seq), CRISPR interference and activation 149 (CRISPRi/a), variant abundance by massively parallel sequencing 22 (VAMP-seq), RNA FlowFISH 85 and Cell Painting 84 .”
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607
The “All of Us” Research Program
The All of Us Research Program Investigators (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1809937 · Cited by 2,440
Expanded encyclopaedias of DNA elements in the human and mouse genomes
The ENCODE Project Consortium, Abascal, F., Acosta, R., Addleman, N. J., Adrian, J., Afzal, V., Ai, R., Aken, B., Akiyama, J. A., Jammal, O. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2493-4 · Cited by 2,378
Self-citationPredicting effects of noncoding variants with deep learning–based sequence model
Zhou, J., & Troyanskaya, O. G. (2015) · Nature Methods · doi:10.1038/nmeth.3547 · Cited by 2,338
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03205-y · Cited by 2,213
Self-citationCRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962 · cited 1×
“• Dissection of a GWAS locus led to identification of BCL11A as a repressor of fetal haemoglobin and development of CRISPR editors for sickle-cell disease 50,166,167 .”
Dixit, A., Parnas, O., Li, B., Chen, J., Fulco, C. P., Jerby-Arnon, L., Marjanovic, N. D., Dionne, D., Burks, T., Raychowdhury, R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.038 · Cited by 1,863
Genome-wide association studies
Uffelmann, E., Huang, Q. Q., Munung, N. S., de Vries, J., Okada, Y., Martin, A. R., Martin, H. C., Lappalainen, T., & Posthuma, D. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00056-9 · Cited by 1,849
The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource
Sollis, E., Mosaku, A., Abid, A., Buniello, A., Cerezo, M., Gil, L., Groza, T., Güneş, O., Hall, P., Hayhurst, J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1010 · Cited by 1,641
The Missing Diversity in Human Genetic Studies
Sirugo, G., Williams, S. M., & Tishkoff, S. A. (2019) · Cell · doi:10.1016/j.cell.2019.02.048 · Cited by 1,516
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis
Granja, J. M., Corces, M. R., Pierce, S. E., Bagdatli, S. T., Choudhry, H., Chang, H. Y., & Greenleaf, W. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00790-6 · Cited by 1,392 · cited 2×
“…to identify candidate cis -regulatory elements, detect probable transcription factor binding sites 35,102 and predict enhancer–gene relationships 36,37,64,86,88,93 ; (2) test more than a million noncoding variants in enhancer activity reporter assays 51,52,56,57,103 ; (3) test thousands of…”
FTO Obesity Variant Circuitry and Adipocyte Browning in Humans
Claussnitzer, M., Dankel, S. N., Kim, K.-H., Quon, G., Meuleman, W., Haugen, C., Glunk, V., Sousa, I. S., Beaudry, J. L., Puviindran, V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502214 · Cited by 1,332
Effective gene expression prediction from sequence by integrating long-range interactions
Avsec, Ž., Agarwal, V., Visentin, D., Ledsam, J. R., Grabska-Barwinska, A., Taylor, K. R., Assael, Y., Jumper, J., Kohli, P., & Kelley, D. R. (2021) · Nature Methods · doi:10.1038/s41592-021-01252-x · Cited by 1,326 · cited 5×
“…identify candidate cis -regulatory elements, detect probable transcription factor binding sites 35,102 and predict enhancer–gene relationships 36,37,64,86,88,93 ; (2) test more than a million noncoding variants in enhancer activity reporter assays 51,52,56,57,103 ; (3) test thousands of noncoding…”
InfluentialSelf-citationObesity-associated variants within FTO form long-range functional connections with IRX3
Smemo, S., Tena, J. J., Kim, K.-H., Gamazon, E. R., Sakabe, N. J., Gómez-Marín, C., Aneas, I., Credidio, F. L., Sobreira, D. R., Wasserman, N. F., et al. (2014) · Nature · doi:10.1038/nature13138 · Cited by 1,219
A reference map of the human binary protein interactome
Luck, K., Kim, D.-K., Lambourne, L., Spirohn, K., Begg, B. E., Bian, W., Brignall, R., Cafarelli, T., Campos-Laborie, F. J., Charloteaux, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2188-x · Cited by 1,197 · cited 3×
“…and reprogramming 70,108–110 , study how genes and proteins interact in molecular networks, including by mapping protein–protein interactions 25 and conducting large-scale Perturb-seq 77–79 , and assess how CRISPR-based perturbations or natural genetic variation across individuals affects…”
Self-citationAdamson, B., Norman, T. M., Jost, M., Cho, M. Y., Nuñez, J. K., Chen, Y., Villalta, J. E., Gilbert, L. A., Horlbeck, M. A., Hein, M. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.048 · Cited by 1,193 · cited 3×
“To build these maps, we will collect longitudinal multiomic data across dynamic cellular processes including differentiation and reprogramming 70,108–110 , study how genes and proteins interact in molecular networks, including by mapping protein–protein interactions 25 and conducting large-scale Perturb-seq 77–79 , an…”
Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin
Ma, S., Zhang, B., LaFave, L. M., Earl, A. S., Chiang, Z., Hu, Y., Ding, J., Brack, A., Kartha, V. K., Tay, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.056 · Cited by 1,146
Self-citationFrom noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140 · cited 1×
“Learning basic and disease biology: • Expression QTL (eQTL) and gene-knockdown studies of a GWAS locus for coronary artery disease identified sortilin ( SORT1 ) as a regulator of low-density lipoprotein (LDL) cholesterol levels and elucidated its molecular function in LDL uptake 158,159 .”
Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq
Arnold, C. D., Gerlach, D., Stelzer, C., Boryń, Ł. M., Rath, M., & Stark, A. (2013) · Science · doi:10.1126/science.1232542 · Cited by 1,125 · cited 4×
“…approaches are shown, including 10x Multiome, SHARE-seq 70 and Parse Evercode 71 , MPRAs 52,56,57 , self-transcribing assay of RNA reporters 51 (STARR-seq), CRISPR interference and activation 149 (CRISPRi/a), variant abundance by massively parallel sequencing 22 (VAMP-seq), RNA FlowFISH 85…”
InfluentialA simple new approach to variable selection in regression, with application to genetic fine mapping
Wang, G., Sarkar, A., Carbonetto, P., & Stephens, M. (2020) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/rssb.12388 · Cited by 1,121
Activity-by-contact model of enhancer–promoter regulation from thousands of CRISPR perturbations
Fulco, C. P., Nasser, J., Jones, T. R., Munson, G., Bergman, D. T., Subramanian, V., Grossman, S. R., Anyoha, R., Doughty, B. R., Patwardhan, T. A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0538-0 · Cited by 1,111
Self-citationFinucane, H. K., Reshef, Y. A., Anttila, V., Slowikowski, K., Gusev, A., Byrnes, A., Gazal, S., Loh, P.-R., Lareau, C., Shoresh, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0081-4 · Cited by 1,097
Self-citationBray, M.-A., Singh, S., Han, H., Davis, C. T., Borgeson, B., Hartland, C., Kost-Alimova, M., Gustafsdottir, S. M., Gibson, C. C., & Carpenter, A. E. (2016) · Nature Protocols · doi:10.1038/nprot.2016.105 · Cited by 1,090
Self-citationMillion Veteran Program: A mega-biobank to study genetic influences on health and disease
Gaziano, J. M., Concato, J., Brophy, M., Fiore, L., Pyarajan, S., Breeling, J., Whitbourne, S., Deen, J., Shannon, C., Humphries, D., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.09.016 · Cited by 1,055
A structural variation reference for medical and population genetics
Collins, R. L., Brand, H., Karczewski, K. J., Zhao, X., Alföldi, J., Francioli, L. C., Khera, A. V., Lowther, C., Gauthier, L. D., Wang, H., et al. (2020) · Nature · doi:10.1038/s41586-020-2287-8 · Cited by 1,037
Self-citationThe power of genetic diversity in genome-wide association studies of lipids
Graham, S. E., Clarke, S. L., Wu, K.-H. H., Kanoni, S., Zajac, G. J. M., Ramdas, S., Surakka, I., Ntalla, I., Vedantam, S., Winkler, T. W., et al. (2021) · Nature · doi:10.1038/s41586-021-04064-3 · Cited by 972
Self-citationMAGIC, Heid, I. M., Jackson, A. U., Randall, J. C., Winkler, T. W., Qi, L., Steinthorsdottir, V., Thorleifsson, G., Zillikens, M. C., Speliotes, E. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.685 · Cited by 931
Self-citationHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886 · cited 3×
“• Dissection of a GWAS locus led to identification of BCL11A as a repressor of fetal haemoglobin and development of CRISPR editors for sickle-cell disease 50,166,167 .”
Self-citationAccurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Self-citationFINEMAP: efficient variable selection using summary data from genome-wide association studies
Benner, C., Spencer, C. C. A., Havulinna, A. S., Salomaa, V., Ripatti, S., & Pirinen, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw018 · Cited by 815
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq
Replogle, J. M., Saunders, R. A., Pogson, A. N., Hussmann, J. A., Lenail, A., Guna, A., Mascibroda, L., Wagner, E. J., Adelman, K., Lithwick-Yanai, G., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.013 · Cited by 795
Benchmarking algorithms for gene regulatory network inference from single-cell transcriptomic data
Pratapa, A., Jalihal, A. P., Law, J. N., Bharadwaj, A., & Murali, T. M. (2020) · Nature Methods · doi:10.1038/s41592-019-0690-6 · Cited by 792 · cited 1×
“…predictive models that use snRNA-seq and snATAC-seq as inputs could be developed using data from cellular models, in which predictions can be directly evaluated with matching perturbation data, and applied to make cell-type-specific predictions in cell types from primary tissues 36,37,86,111 .”
Melnikov, A., Murugan, A., Zhang, X., Tesileanu, T., Wang, L., Rogov, P., Feizi, S., Gnirke, A., Callan, C. G., Kinney, J. B., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2137 · Cited by 711
A brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697
Self-citationSingle-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease
Yazar, S., Alquicira-Hernandez, J., Wing, K., Senabouth, A., Gordon, M. G., Andersen, S., Lu, Q., Rowson, A., Taylor, T. R. P., Clarke, L., et al. (2022) · Science · doi:10.1126/science.abf3041 · Cited by 682
Genome-wide enhancer maps link risk variants to disease genes
Nasser, J., Bergman, D. T., Fulco, C. P., Guckelberger, P., Doughty, B. R., Patwardhan, T. A., Jones, T. R., Nguyen, T. H., Ulirsch, J. C., Lekschas, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03446-x · Cited by 669 · cited 3×
“To systematically evaluate and calibrate such models, we will build benchmarking pipelines that compare predictions to perturbation data, including from IGVF functional characterization experiments as well as external sources such as QTLs, GWAS and genome sequencing studies 87,88,93,94 .”
Self-citationRNA splicing is a primary link between genetic variation and disease
Li, Y. I., van de Geijn, B., Raj, A., Knowles, D. A., Petti, A. A., Golan, D., Gilad, Y., & Pritchard, J. K. (2016) · Science · doi:10.1126/science.aad9417 · Cited by 660
Self-citationSystematic mapping of functional enhancer–promoter connections with CRISPR interference
Fulco, C. P., Munschauer, M., Anyoha, R., Munson, G., Grossman, S. R., Perez, E. M., Kane, M., Cleary, B., Lander, E. S., & Engreitz, J. M. (2016) · Science · doi:10.1126/science.aag2445 · Cited by 643
Self-citationMULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices
McGinnis, C. S., Patterson, D. M., Winkler, J., Conrad, D. N., Hein, M. Y., Srivastava, V., Hu, J. L., Murrow, L. M., Weissman, J. S., Werb, Z., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0433-8 · Cited by 643
A Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens
Gasperini, M., Hill, A. J., McFaline-Figueroa, J. L., Martin, B., Kim, S., Zhang, M. D., Jackson, D., Leith, A., Schreiber, J., Noble, W. S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.029 · Cited by 613
Self-citationBase-resolution models of transcription-factor binding reveal soft motif syntax
Avsec, Ž., Weilert, M., Shrikumar, A., Krueger, S., Alexandari, A., Dalal, K., Fropf, R., McAnany, C., Gagneur, J., Kundaje, A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00782-6 · Cited by 610 · cited 2×
“…that generalize across contexts—for example, to link genetic variants to effects on transcription factor binding and chromatin accessibility 57,61–64 , connect regulatory elements to their target genes 64,85,86 , or identify causal genes and cell types enriched for heritability for complex…”
Self-citationThe human body at cellular resolution: the NIH Human Biomolecular Atlas Program
HuBMAP Consortium, Writing Group, Snyder, M. P., Lin, S., Posgai, A., Atkinson, M., Regev, A., Rood, J., Rozenblatt-Rosen, O., Gaffney, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1629-x · Cited by 595
Self-citationWidespread macromolecular interaction perturbations in human genetic disorders
Sahni, N., Yi, S., Taipale, M., Fuxman Bass, J. I., Coulombe-Huntington, J., Yang, F., Peng, J., Weile, J., Karras, G. I., Wang, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.013 · Cited by 594 · cited 2×
“We will improve the annotation of protein-coding missense variants by applying high-throughput technologies 25,80–83 to experimentally characterize the effects of more than 200,000 missense variants on protein and cellular properties, including protein stability, subcellular localization, cell…”
Self-citationPejaver, V., Byrne, A. B., Feng, B.-J., Pagel, K. A., Mooney, S. D., Karchin, R., O’Donnell-Luria, A., Harrison, S. M., Tavtigian, S. V., Greenblatt, M. S., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.10.013 · Cited by 589 · cited 1×
“We will assess the extent to which experimental data or computational predictions correctly identify variants previously classified as either pathogenic or benign, and calibrate these analyses for clinical applications 129,130 .”
Self-citationKotliar, D., Veres, A., Nagy, M. A., Tabrizi, S., Hodis, E., Melton, D. A., & Sabeti, P. C. (2019) · eLife · doi:10.7554/elife.43803 · Cited by 563
Building a knowledge graph to enable precision medicine
Chandak, P., Huang, K., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01960-3 · Cited by 522
Critical assessment of methods of protein structure prediction (CASP)—Round XIV
Kryshtafovych, A., Schwede, T., Topf, M., Fidelis, K., & Moult, J. (2021) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26237 · Cited by 503 · cited 2×
“(5) Finally, recent successes by CASP 68 (critical assessment of protein structure prediction), ENCODE 15 (Encyclopedia of DNA Elements) and others 17,21,69 have highlighted how uniting a diverse community of investigators under a common framework can catalyse advances throughout the global scientific community by dev…”
The Human Pangenome Project: a global resource to map genomic diversity
Wang, T., Antonacci-Fulton, L., Howe, K., Lawson, H. A., Lucas, J. K., Phillippy, A. M., Popejoy, A. B., Asri, M., Carson, C., Chaisson, M. J. P., et al. (2022) · Nature · doi:10.1038/s41586-022-04601-8 · Cited by 494 · cited 2×
“…from close interactions with efforts to characterize human genomic variation and assemblies, such as the Human Pangenome Reference Consortium 147 (HPRC), with efforts to catalogue disease-associated variation across ancestries, including All of Us 148 and TOPMed 10 (Trans-Omics for…”
Self-citationKlann, T. S., Black, J. B., Chellappan, M., Safi, A., Song, L., Hilton, I. B., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3853 · Cited by 447
Self-citationMultiplex assessment of protein variant abundance by massively parallel sequencing
Matreyek, K. A., Starita, L. M., Stephany, J. J., Martin, B., Chiasson, M. A., Gray, V. E., Kircher, M., Khechaduri, A., Dines, J. N., Hause, R. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0122-z · Cited by 436
Self-citationThe IntAct database: efficient access to fine-grained molecular interaction data
del Toro, N., Shrivastava, A., Ragueneau, E., Meldal, B., Combe, C., Barrera, E., Perfetto, L., How, K., Ratan, P., Shirodkar, G., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1006 · Cited by 405
High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis
Patwardhan, R. P., Lee, C., Litvin, O., Young, D. L., Pe'er, D., & Shendure, J. (2009) · Nature Biotechnology · doi:10.1038/nbt.1589 · Cited by 377 · cited 2×
“…predict enhancer–gene relationships 36,37,64,86,88,93 ; (2) test more than a million noncoding variants in enhancer activity reporter assays 51,52,56,57,103 ; (3) test thousands of noncoding variants for effects on expression through fine-mapping of eQTLs or direct CRISPR-based genome editing…”
Self-citationFunctionally informed fine-mapping and polygenic localization of complex trait heritability
Weissbrod, O., Hormozdiari, F., Benner, C., Cui, R., Ulirsch, J., Gazal, S., Schoech, A. P., van de Geijn, B., Reshef, Y., Márquez-Luna, C., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00735-5 · Cited by 364
Self-citationDiversity and inclusion in genomic research: why the uneven progress?
Bentley, A. R., Callier, S., & Rotimi, C. N. (2017) · Journal of Community Genetics · doi:10.1007/s12687-017-0316-6 · Cited by 357
Inoue, F., Kircher, M., Martin, B., Cooper, G. M., Witten, D. M., McManus, M. T., Ahituv, N., & Shendure, J. (2017) · Genome Research · doi:10.1101/gr.212092.116 · Cited by 331 · cited 1×
“…enhancer–gene relationships 36,37,64,86,88,93 ; (2) test more than a million noncoding variants in enhancer activity reporter assays 51,52,56,57,103 ; (3) test thousands of noncoding variants for effects on expression through fine-mapping of eQTLs or direct CRISPR-based genome editing…”
Self-citationMassively parallel assessment of human variants with base editor screens
Hanna, R. E., Hegde, M., Fagre, C. R., DeWeirdt, P. C., Sangree, A. K., Szegletes, Z., Griffith, A., Feeley, M. N., Sanson, K. R., Baidi, Y., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.012 · Cited by 316
Massively parallel assessment of human variants with base editor screens
Hanna, R. E., Hegde, M., Fagre, C. R., DeWeirdt, P. C., Sangree, A. K., Szegletes, Z., Griffith, A., Feeley, M. N., Sanson, K. R., Baidi, Y., et al. (2020) · doi:10.1101/2020.05.17.100818 · Cited by 314 · cited 1×
“…relationships 36,37,64,86,88,93 ; (2) test more than a million noncoding variants in enhancer activity reporter assays 51,52,56,57,103 ; (3) test thousands of noncoding variants for effects on expression through fine-mapping of eQTLs or direct CRISPR-based genome editing 17,42–45, 47 ;”
Zhang, Y., Qi, G., Park, J.-H., & Chatterjee, N. (2018) · Nature Genetics · doi:10.1038/s41588-018-0193-x · Cited by 288 · cited 1×
“For many diseases, an individual’s risk is likely to be determined by a combination of thousands of independently acting variants 112,113 —including for diseases presumed to follow Mendelian inheritance patterns, where penetrance and expressivity may include a polygenic component 114 .”
Targeted Perturb-seq enables genome-scale genetic screens in single cells
Schraivogel, D., Gschwind, A. R., Milbank, J. H., Leonce, D. R., Jakob, P., Mathur, L., Korbel, J. O., Merten, C. A., Velten, L., & Steinmetz, L. M. (2020) · Nature Methods · doi:10.1038/s41592-020-0837-5 · Cited by 245
Self-citationA systematic evaluation of the design and context dependencies of massively parallel reporter assays
Klein, J. C., Agarwal, V., Inoue, F., Keith, A., Martin, B., Kircher, M., Ahituv, N., & Shendure, J. (2020) · Nature Methods · doi:10.1038/s41592-020-0965-y · Cited by 226
Functional inference of gene regulation using single-cell multi-omics
Kartha, V. K., Duarte, F. M., Hu, Y., Ma, S., Chew, J. G., Lareau, C. A., Earl, A., Burkett, Z. D., Kohlway, A. S., Lebofsky, R., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100166 · Cited by 224
Self-citationDiscovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens
Morris, J. A., Caragine, C., Daniloski, Z., Domingo, J., Barry, T., Lu, L., Davis, K., Ziosi, M., Glinos, D. A., Hao, S., et al. (2023) · Science · doi:10.1126/science.adh7699 · Cited by 208
Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
Rajabli, F., Feliciano, B. E., Celis, K., Hamilton-Nelson, K. L., Whitehead, P. L., Adams, L. D., Bussies, P. L., Manrique, C. P., Rodriguez, A., Rodriguez, V., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007791 · Cited by 206
Genetic determinants of co-accessible chromatin regions in activated T cells across humans
Gate, R. E., Cheng, C. S., Aiden, A. P., Siba, A., Tabaka, M., Lituiev, D., Machol, I., Gordon, M. G., Subramaniam, M., Shamim, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0156-2 · Cited by 181 · cited 1×
“We will characterize the effects of these perturbations using diverse assays, including measurements of chromatin accessibility 76 , gene expression 77–79 , protein expression and activity 25,80–83 , and molecular and cellular phenotypes 84 .”
Massively parallel characterization of transcriptional regulatory elements
Agarwal, V., Inoue, F., Schubach, M., Penzar, D., Martin, B. K., Dash, P. M., Keukeleire, P., Zhang, Z., Sohota, A., Zhao, J., et al. (2025) · Nature · doi:10.1038/s41586-024-08430-9 · Cited by 146
Self-citationscBasset: Sequence-based modeling of single cell ATAC-seq using convolutional neural networks
Yuan, H., & Kelley, D. R. (2021) · doi:10.1101/2021.09.08.459495 · Cited by 138
Karollus, A., Mauermeier, T., & Gagneur, J. (2023) · Genome Biology · doi:10.1186/s13059-023-02899-9 · Cited by 128 · cited 2×
“To systematically evaluate and calibrate such models, we will build benchmarking pipelines that compare predictions to perturbation data, including from IGVF functional characterization experiments as well as external sources such as QTLs, GWAS and genome sequencing studies 87,88,93,94 .”
Shi, H., Gazal, S., Kanai, M., Koch, E. M., Schoech, A. P., Siewert, K. M., Kim, S. S., Luo, Y., Amariuta, T., Huang, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21286-1 · Cited by 119
Self-citationHold out the genome: a roadmap to solving the cis-regulatory code
de Boer, C. G., & Taipale, J. (2024) · Nature · doi:10.1038/s41586-023-06661-w · Cited by 107 · cited 1×
“Despite advances by ENCODE, GTEx and other projects, we still lack models that can make accurate causal inferences about how genomic variation affects gene regulation 94,100,101 .”
Mondo: Unifying diseases for the world, by the world
Vasilevsky, N. A., Matentzoglu, N. A., Toro, S., Flack, J. E., Hegde, H., Unni, D. R., Alyea, G. F., Amberger, J. S., Babb, L., Balhoff, J. P., et al. (2022) · doi:10.1101/2022.04.13.22273750 · Cited by 107
Vockley, C. M., Guo, C., Majoros, W. H., Nodzenski, M., Scholtens, D. M., Hayes, M. G., Lowe, W. L., & Reddy, T. E. (2015) · Genome Research · doi:10.1101/gr.190090.115 · Cited by 99
Self-citationThe distribution of common-variant effect sizes
O’Connor, L. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00901-3 · Cited by 81
Research works printed but not linked: 76
- Loos, R. J. F. 15 years of genome-wide association studies and no signs of slowing down. Nat. Commun. 11, 5900 (2020). · DOI · Paper page
- Green, E. D. et al. Strategic vision for improving human health at the forefront of genomics. Nature 586, 683–692 (2020). · DOI · Paper page
- Zhou, W. et al. Global Biobank Meta-analysis Initiative: powering genetic discovery across human disease. Cell Genom 2, 100192 (2022). · DOI · Paper page
- Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628–634 (2021). · DOI · Paper page
- Karczewski, K. J. et al. Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes. Cell Genomics 2, 100168 (2022). · DOI · Paper page
- Doolittle, W. F., Brunet, T. D. P., Linquist, S. & Gregory, T. R. Distinguishing between ‘function’ and ‘effect’ in genome biology. Genome Biol. Evol. 6, 1234–1237 (2014). · DOI
- Kellis, M. et al. Defining functional DNA elements in the human genome. Proc. Natl. Acad. Sci. USA 111, 6131–6138 (2014). · DOI · Paper page
- Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015). · DOI · Paper page
- Esposito, D. et al. MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect. Genome Biol. 20, 223 (2019). · DOI · Paper page
- Pacini, C. et al. Integrated cross-study datasets of genetic dependencies in cancer. Nat. Commun. 12, 1661 (2021). · DOI · Paper page
- Abdellaoui, A., Yengo, L., Verweij, K. J. H. & Visscher, P. M. 15 years of GWAS discovery: realizing the promise. Am. J. Hum. Genet. 110, 179–194 (2023). · DOI · Paper page
- Rehm, H. L. & Fowler, D. M. Keeping up with the genomes: scaling genomic variant interpretation. Genome Med. 12, 5 (2019). · DOI
- Lappalainen, T. & MacArthur, D. G. From variant to function in human disease genetics. Science 373, 1464–1468 (2021). · DOI · Paper page
- Findlay, G. M. Linking genome variants to disease: scalable approaches to test the functional impact of human mutations. Hum. Mol. Genet. 30, R187–R197 (2021). · DOI · Paper page
- Hu, Y. et al. Single-cell multi-scale footprinting reveals the modular organization of DNA regulatory elements. Preprint at bioRxiv https://doi.org/10.1101/2023.03.28.533945 (2023). · DOI
- Wang, Q. S. et al. Leveraging supervised learning for functionally informed fine-mapping of cis-eQTLs identifies an additional 20,913 putative causal eQTLs. Nat. Commun. 12, 3394 (2021). · DOI · Paper page
- Cuella-Martin, R. et al. Functional interrogation of DNA damage response variants with base editing screens. Cell 184, 1081–1097.e19 (2021). · DOI · Paper page
- Martin-Rufino, J. D. et al. Massively parallel base editing to map variant effects in human hematopoiesis. Cell 186, 2456–2474.e24 (2023). · DOI · Paper page
- Bergman, D. T. et al. Compatibility rules of human enhancer and promoter sequences. Nature 607, 176–184 (2022). · DOI · Paper page
- Beer, M. A. Predicting enhancer activity and variant impact using gkm-SVM. Hum. Mutat. 38, 1251–1258 (2017). · DOI
- Chen, K. M., Wong, A. K., Troyanskaya, O. G. & Zhou, J. A sequence-based global map of regulatory activity for deciphering human genetics. Nat. Genet. 54, 940–949 (2022). · DOI · Paper page
- Han, J.-D. J. Understanding biological functions through molecular networks. Cell Res. 18, 224–237 (2008). · DOI · Paper page
- The Critical Assessment of Genome Interpretation Consortium. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods. Genome Biol. 25, 53 (2024). This paper reports a collaborative effort to independently assess computational models for interpreting the effects of variants on molecular phenotypes and disease risk, and demonstrates their utility in clinical and research applications. · DOI · Paper page
- Tran, V. et al. High sensitivity single cell RNA sequencing with split pool barcoding. Preprint at bioRxiv https://doi.org/10.1101/2022.08.27.505512 (2022). · DOI · Paper page
- Xu, Y. et al. An atlas of genetic scores to predict multi-omic traits. Nature 616, 123–131 (2023). · DOI · Paper page
- Nathan, A. et al. Single-cell eQTL models reveal dynamic T cell state dependence of disease loci. Nature 606, 120–128 (2022). · DOI · Paper page
- Perez, R. K. et al. Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus. Science 376, eabf1970 (2022). · DOI · Paper page
- Fayer, S. et al. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53 and PTEN. Am. J. Hum. Genet. 108, 2248–2258 (2021). This study illustrates how experimentally derived variant effect maps can have high clinical utility in interpreting variants for Mendelian diseases. · DOI · Paper page
- Starita, L. M. et al. Massively parallel functional analysis of BRCA1 RING domain variants. Genetics 200, 413–422 (2015). · DOI · Paper page
- Sun, S. et al. An extended set of yeast-based functional assays accurately identifies human disease mutations. Genome Res. 26, 670–680 (2016). · DOI · Paper page
- Sakaue, S. et al. Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles. Nat. Genet. 56, 615–626 (2024). · DOI
- Weeks, E. M. et al. Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. Nat. Genet. 55, 1267–1276 (2023). · DOI · Paper page
- Schnitzler, G. R. et al. Convergence of coronary artery disease genes onto endothelial cell programs. Nature 626, 799–807 (2024). · DOI · Paper page
- Forgetta, V. et al. An effector index to predict target genes at GWAS loci. Hum. Genet. 141, 1431–1447 (2022). · DOI
- Ghoussaini, M. et al. Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 49, D1311–D1320 (2021). · DOI · Paper page
- Gschwind, A. R. et al. an encyclopedia of enhancer-gene regulatory interactions in the human genome. Preprint at bioRxiv https://doi.org/10.1101/2023.11.09.563812 (2023). · DOI · Paper page
- The Complex Trait Consortium. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36, 1133–1137 (2024). · DOI · Paper page
- Hogan, A. et al. Knowledge Graphs. Preprint at arXiv https://doi.org/10.48550/arXiv.2003.02320 (2020). · DOI
- Feng, F. et al. GenomicKB: a knowledge graph for the human genome. Nucleic Acids Res. 51, D950–D956 (2023). · DOI
- Lobentanzer, S. et al. Democratizing knowledge representation with BioCypher. Nat. Biotechnol. 41, 1056–1059 (2023). · DOI
- Ambrosini, G. et al. Insights gained from a comprehensive all-against-all transcription factor binding motif benchmarking study. Genome Biol. 21, 114 (2020). · DOI
- Xie, S., Duan, J., Li, B., Zhou, P. & Hon, G. C. Multiplexed engineering and analysis of combinatorial enhancer activity in single cells. Mol. Cell 66, 285–299.e5 (2017). · DOI · Paper page
- Reilly, S. K. et al. Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using HCR–FlowFISH. Nat. Genet. 53, 1166–1176 (2021). · DOI
- Daniel, B. et al. Divergent clonal differentiation trajectories of T cell exhaustion. Nat. Immunol. 23, 1614–1627 (2022). · DOI · Paper page
- Rebboah, E. et al. Mapping and modeling the genomic basis of differential RNA isoform expression at single-cell resolution with LR-Split-seq. Genome Biol. 22, 286 (2021). · DOI · Paper page
- Lewis, C. M. & Vassos, E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 12, 44 (2020). · DOI · Paper page
- Hekselman, I. & Yeger-Lotem, E. Mechanisms of tissue and cell-type specificity in heritable traits and diseases. Nat. Rev. Genet. 21, 137–150 (2020). · DOI
- Weissbrod, O. et al. Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores. Nat. Genet. 54, 450–458 (2022). · DOI · Paper page
- Goossens, G. H., Jocken, J. W. E. & Blaak, E. E. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat. Rev. Endocrinol. 17, 47–66 (2021). · DOI · Paper page
- Blue, E. E., Horimoto, A. R. V. R., Mukherjee, S., Wijsman, E. M. & Thornton, T. A. Local ancestry at APOE modifies Alzheimer’s disease risk in Caribbean Hispanics. Alzheimers Dement. 15, 1524–1532 (2019). · DOI · Paper page
- Baxter, S. M. et al. Centers for Mendelian genomics: a decade of facilitating gene discovery. Genet. Med. 24, 784–797 (2022). · DOI
- Costanzo, M. C. et al. The Type 2 Diabetes Knowledge Portal: an open access genetic resource dedicated to type 2 diabetes and related traits. Cell Metab. 35, 695–710.e6 (2023). · DOI
- Scott, A. et al. Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome. Genome Biol. 23, 266 (2022). · DOI · Paper page
- Radford, E. J. et al. Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation. Nat. Commun. 14, 7702 2023 · DOI · Paper page
- Miller, D. T. et al. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 24, 1407–1414 (2022). · DOI · Paper page
- Brnich, S. E. et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019). · DOI · Paper page
- Musunuru, K. & Kathiresan, S. Genetics of common, complex coronary artery disease. Cell 177, 132–145 (2019). · DOI · Paper page
- Hamilton, M. C. et al. Systematic elucidation of genetic mechanisms underlying cholesterol uptake. Cell Genomics 3, 100304 (2023). · DOI · Paper page
- Hou, K. et al. Causal effects on complex traits are similar for common variants across segments of different continental ancestries within admixed individuals. Nat. Genet. 55, 549–558 (2023). · DOI
- 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015). · DOI · Paper page
- Kanoni, S. et al. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis. Genome Biol. 23, 268 (2022). · DOI
- Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415–1424 (2021). · DOI · Paper page
- Aragam, K. G. et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet. 54, 1803–1815 (2022). · DOI · Paper page
- Tcheandjieu, C. et al. Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. Nat. Med. 28, 1679–1692 (2022). · DOI · Paper page
- Threadgill, D. W., Miller, D. R., Churchill, G. A. & de Villena, F. P.-M. The collaborative cross: a recombinant inbred mouse population for the systems genetic era. ILAR J. 52, 24–31 (2011). · DOI · Paper page
- Fowler, D. M. et al. An Atlas of Variant Effects to understand the genome at nucleotide resolution. Genome Biol. 24, 147 (2023). · DOI · Paper page
- Schatz, M. C. et al. Inverting the model of genomics data sharing with the NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space. Cell Genomics 2, 100085 (2022). · DOI · Paper page
- Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766–D773 (2019). · DOI · Paper page
- Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000). · DOI · Paper page
- Köhler, S. et al. The Human Phenotype Ontology in 2021. Nucleic Acids Res. 49, D1207–D1217 (2021). · DOI · Paper page
- Amberger, J. S., Bocchini, C. A., Scott, A. F. & Hamosh, A. OMIM.org: leveraging knowledge across phenotype–gene relationships. Nucleic Acids Res. 47, D1038–D1043 (2019). · DOI · Paper page
- Kjolby, M. et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 12, 213–223 (2010). · DOI · Paper page
- Graham, D. B. & Xavier, R. J. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 578, 527–539 (2020). · DOI · Paper page
- Kim, S., Eun, H. S. & Jo, E.-K. Roles of autophagy-related genes in the pathogenesis of inflammatory bowel disease. Cells 8, 77 (2019). · DOI
- Singh, N. K., Singh, N. N., Androphy, E. J. & Singh, R. N. Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron. Mol. Cell. Biol. 26, 1333 (2006). · DOI · Paper page
- Hua, Y. et al. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev. 24, 1634 (2010). · DOI · Paper page
Cited by
Rubin, A. F., Stone, J., Bianchi, A. H., Capodanno, B. J., Da, E. Y., Dias, M., Esposito, D., Frazer, J., Fu, Y., Grindstaff, S. B., et al. (2025) · Genome Biology · doi:10.1186/s13059-025-03476-y · Cited by 80
Self-citationLambourne, L., Mattioli, K., Santoso, C., Sheynkman, G., Inukai, S., Kaundal, B., Berenson, A., Spirohn-Fitzgerald, K., Bhattacharjee, A., Rothman, E., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.03.004 · Cited by 42
Self-citationMaveMD: A functional data resource for genomic medicine
McEwen, A. E., Stone, J., Tejura, M., Gupta, P., Capodanno, B. J., Da, E. Y., Grindstaff, S. B., Moore, N., Reinhart, D., Snyder, A. E., et al. (2025) · doi:10.1101/2025.11.15.25336228 · Cited by 5
Self-citationLin, J., Wu, S., Lin, C., Jin, S., Chen, L., Luo, J., Xu, S., Jin, L., Yu, M., Zheng, Y., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.050327
Metadata
- Authors
- IGVF Consortium, Writing group (ordered by contribution), Engreitz, J. M., Lawson, H. A., Singh, H., Starita, L. M., Hon, G. C., Carter, H., Sahni, N., Reddy, T. E., Lin, X., Li, Y., Munshi, N. V., Chahrour, M. H., Boyle, A. P., Hitz, B. C., Mortazavi, A., Craven, M., Mohlke, K. L., Pinello, L., Wang, T., Steering Committee Co-Chairs (alphabetical by last name), Kundaje, A., Yue, F., Code of Conduct Committee (alphabetical by last name), Cody, S., Farrell, N. P., Love, M. I., Muffley, L. A., Pazin, M. J., Reese, F., Van Buren, E., Working Group and Focus Group Co-Chairs (alphabetical by last name), Catalog, Dey, K. K., Characterization, Kircher, M., Computational Analysis, M., Ma, J., Radivojac, P., Project Design, Balliu, B., Mapping, Williams, B. A., Networks, Huangfu, D., Pipelines, S. A., Cardiometabolic, Park, C. Y., Quertermous, T., Networks, C. P. A., Das, J., Variants, C., Calderwood, M. A., Fowler, D. M., Vidal, M., CRISPR, Ferreira, L., Function, D. A. S., Mooney, S. D., Pejaver, V., Variants, E., Zhao, J., Evolution, Gazal, S., Koch, E., Reilly, S. K., Sunyaev, S., Imaging, Carpenter, A. E., Immune, Buenrostro, J. D., Leslie, C. S., Savage, R. E., Populations, I. O. D., Giric, S., iPSC, Luo, C., Plath, K., MPRA, Barrera, A., Schubach, M., Variants, N., Gschwind, A. R., Moore, J. E., Neuro, Ahituv, N., Function, P. I. A., Yi, S. S., QTL/Statgen, Hallgrimsdottir, I., Gaulton, K. J., Sakaue, S., Cell, S., Booeshaghi, S., Mattei, E., Nair, S., Pachter, L., Wang, A. T., Characterization Awards (contact PI, M. (. B. L. N., UM1HG011966, Shendure, J., Agarwal, V., Blair, A., Chalkiadakis, T., Chardon, F. M., Dash, P. M., Deng, C., Hamazaki, N., Keukeleire, P., Kubo, C., Lalanne, J.-B., Maass, T., Martin, B., McDiarmid, T. A., Nobuhara, M., Page, N. F., Regalado, S., Sims, J., Ushiki, A., UM1HG011969, Best, S. M., Boyle, G., Camp, N., Casadei, S., Da, E. Y., Dawood, M., Dawson, S. C., Fayer, S., Hamm, A., James, R. G., Jarvik, G. P., McEwen, A. E., Moore, N., Pendyala, S., Popp, N. A., Post, M., Rubin, A. F., Smith, N. T., Stone, J., Tejura, M., Wang, Z. R., Wheelock, M. K., Woo, I., Zapp, B. D., UM1HG011972, Amgalan, D., Aradhana, A., Arana, S. M., Bassik, M. C., Bauman, J. R., Bhattacharya, A., Cai, X. S., Chen, Z., Conley, S., Deshpande, S., Doughty, B. R., Du, P. P., Galante, J. A., Gifford, C., Greenleaf, W. J., Guo, K., Gupta, R., Isobe, S., Jagoda, E., Jain, N., Jones, H., Kang, H. Y., Kim, S. H., Kim, Y., Klemm, S., Kundu, R., Kundu, S., Lago-Docampo, M., Lee-Yow, Y. C., Levin-Konigsberg, R., Li, D. Y., Lindenhofer, D., Ma, X. R., Marinov, G. K., Martyn, G. E., McCreery, C. V., Metzl-Raz, E., Monteiro, J. P., Montgomery, M. T., Mualim, K. S., Munger, C., Munson, G., Nguyen, T. C., Nguyen, T., Palmisano, B. T., Pampari, A., Rabinovitch, M., Ramste, M., Ray, J., Roy, K. R., Rubio, O. M., Schaepe, J. M., Schnitzler, G., Schreiber, J., Sharma, D., Sheth, M. U., Shi, H., Singh, V., Sinha, R., Steinmetz, L. M., Tan, J., Tan, A., Tycko, J., Valbuena, R. C., Amiri, V. V. P., van Kooten, M. J. F. M., Vaughan-Jackson, A., Venida, A., Weldy, C. S., Worssam, M. D., Xia, F., Yao, D., Zeng, T., Zhao, Q., Zhou, R., UM1HG011989, Chen, Z. S., Cimini, B. A., Coppin, G., Coté, A. G., Haghighi, M., Hao, T., Hill, D. E., Lacoste, J., Laval, F., Reno, C., Roth, F. P., Singh, S., Spirohn-Fitzgerald, K., Taipale, M., Teelucksingh, T., Tixhon, M., Yadav, A., Yang, Z., UM1HG011996, Kraus, W. L., Armendariz, D. A., Dederich, A. E., Gogate, A., El Hayek, L., Goetsch, S. C., Kaur, K., Kim, H. B., McCoy, M. K., Nzima, M. Z., Pinzón-Arteaga, C. A., Posner, B. A., Schmitz, D. A., Sivakumar, S., Sundarrajan, A., Wang, L., Wang, Y., Wu, J., Xu, L., Xu, J., Yu, L., Zhang, Y., Zhao, H., Zhou, Q., UM1HG012003, Won, H., Bell, J. L., Broadaway, K. A., Degner, K. N., Etheridge, A. S., Koller, B. H., Mah, W., Mu, W., Ritola, K. D., Rosen, J. D., Schoenrock, S. A., Sharp, R. A., UM1HG012010, Bauer, D., Lettre, G., Sherwood, R., Becerra, B., Blaine, L. J., Che, E., Francoeur, M. J., Gibbs, E. N., Kim, N., King, E. M., Kleinstiver, B. P., Lecluze, E., Li, Z., Patel, Z. M., Phan, Q. V., Ryu, J., Starr, M. L., Wu, T., UM1HG012053, Gersbach, C. A., Crawford, G. E., Allen, A. S., Majoros, W. H., Iglesias, N., Rai, R., Venukuttan, R., Li, B., Anglen, T., Bounds, L. R., Hamilton, M. C., Liu, S., McCutcheon, S. R., McRoberts Amador, C. D., Reisman, S. J., ter Weele, M. A., Bodle, J. C., Streff, H. L., Siklenka, K., Strouse, K., Mapping Awards (contact PI, M. (. B. L. N., UM1HG011986, Bernstein, B. E., Babu, J., Corona, G. B., Dong, K., Duarte, F. M., Durand, N. C., Epstein, C. B., Fan, K., Gaskell, E., Hall, A. W., Ham, A. M., Knudson, M. K., Shoresh, N., Wekhande, S., White, C. M., Xi, W., UM1HG012076, Satpathy, A. T., Corces, M. R., Chang, S. H., Chin, I. M., Gardner, J. M., Gardell, Z. A., Gutierrez, J. C., Johnson, A. W., Kampman, L., Kasowski, M., Lareau, C. A., Liu, V., Ludwig, L. S., McGinnis, C. S., Menon, S., Qualls, A., Sandor, K., Turner, A. W., Ye, C. J., Yin, Y., Zhang, W., UM1HG012077, Wold, B. J., Carilli, M., Cheong, D., Filibam, G., Green, K., Kawauchi, S., Kim, C., Liang, H., Loving, R., Luebbert, L., MacGregor, G., Merchan, A. G., Rebboah, E., Rezaie, N., Sakr, J., Sullivan, D. K., Swarna, N., Trout, D., Upchurch, S., Weber, R., Predictive Modeling Awards (contact PI, M. (. B. L. N., U01HG011952, Castro, C. P., Chou, E., Feng, F., Guerra, A., Huang, Y., Jiang, L., Liu, J., Mills, R. E., Qian, W., Qin, T., Sartor, M. A., Sherpa, R. N., Wang, J., Wang, Y., Welch, J. D., Zhang, Z., Zhao, N., U01HG011967, Mukherjee, S., Page, C. D., Clarke, S., Doty, R. W., Duan, Y., Gordan, R., Ko, K.-Y., Li, S., Li, B., Thomson, A., U01HG012009, Raychaudhuri, S., Price, A., Ali, T. A., Dey, K. K., Durvasula, A., Kellis, M., U01HG012022, Iakoucheva, L. M., Kakati, T., Chen, Y., Benazouz, M., Jain, S., Zeiberg, D., De Paolis Kaluza, M. C., Velyunskiy, M., U01HG012039, Gasch, A., Huang, K., Jin, Y., Lu, Q., Miao, J., Ohtake, M., Scopel, E., Steiner, R. D., Sverchkov, Y., U01HG012064, Weng, Z., Garber, M., Fu, Y., Haas, N., Li, X., Phalke, N., Shan, S. C., Shedd, N., Yu, T., Zhang, Y., Zhou, H., U01HG012069, Battle, A., Jerby, L., Kotler, E., Kundu, S., Marderstein, A. R., Montgomery, S. B., Nigam, A., Padhi, E. M., Patel, A., Pritchard, J., Raine, I., Ramalingam, V., Rodrigues, K. B., Schreiber, J. M., Singhal, A., Sinha, R., Wang, A. T., Network Projects (contact PI, M. (. B. L. N., U01HG012041, Abundis, M., Bisht, D., Chakraborty, T., Fan, J., Hall, D. R., Rarani, Z. H., Jain, A. K., Kaundal, B., Keshari, S., McGrail, D., Pease, N. A., Yi, V. F., U01HG012047, Wu, H., Kannan, S., Song, H., Cai, J., Gao, Z., Kurzion, R., Leu, J. I., Li, F., Liang, D., Ming, G.-L., Musunuru, K., Qiu, Q., Shi, J., Su, Y., Tishkoff, S., Xie, N., Yang, Q., Yang, W., Zhang, H., Zhang, Z., U01HG012051, Beer, M. A., Hadjantonakis, A.-K., Adeniyi, S., Cho, H., Cutler, R., Glenn, R. A., Godovich, D., Hu, N., Jovanic, S., Luo, R., Oh, J. W., Razavi-Mohseni, M., Shigaki, D., Sidoli, S., Vierbuchen, T., Wang, X., Williams, B., Yan, J., Yang, D., Yang, Y., U01HG012059, Sander, M., Gaulton, K. J., Ren, B., Bartosik, W., Indralingam, H. S., Klie, A., Mummey, H., Okino, M.-L., Wang, G., Zemke, N. R., Zhang, K., Zhu, H., U01HG012079, Zaitlen, N., Ernst, J., Langerman, J., Li, T., Sun, Y., U01HG012103, Rudensky, A. Y., Periyakoil, P. K., Gao, V. R., Smith, M. H., Thomas, N. M., Donlin, L. T., Lakhanpal, A., Southard, K. M., Ardy, R. C., Data and Administrative Coordinating Center Awards (contact PI, M. (. B. L. N., U24HG012012, Cherry, J. M., Gerstein, M. B., Andreeva, K., Assis, P. R., Borsari, B., Douglass, E., Dong, S., Gabdank, I., Graham, K., Jolanki, O., Jou, J., Kagda, M. S., Lee, J.-W., Li, M., Lin, K., Miyasato, S. R., Rozowsky, J., Small, C., Spragins, E., Tanaka, F. Y., Whaling, I. M., Youngworth, I. A., Sloan, C. A., U24HG012070, Belter, E., Chen, X., Chisholm, R. L., Dickson, P., Fan, C., Fulton, L., Li, D., Lindsay, T., Luan, Y., Luo, Y., Lyu, H., Ma, X., Macias-Velasco, J., Miga, K. H., Quaid, K., Stitziel, N., Stranger, B. E., Tomlinson, C., Wang, J., Zhang, W., Zhang, B., Zhao, G., Zhuo, X., IGVF Affiliate Member Projects (contact PIs, O. M. (. B. L. N., lab, B., Brennand, K., lab, C., Ciccia, A., Hayward, S. B., Huang, J.-W., Leuzzi, G., Taglialatela, A., Thakar, T., Vaitsiankova, A., lab, D., Dey, K. K., Ali, T. A., lab, G., Kim, A., lab, G., Grimes, H. L., Salomonis, N., lab, G., Gupta, R., Fang, S., Lee-Kim, V., lab, H., Heinig, M., Losert, C., lab, J., Jones, T. R., Donnard, E., Murphy, M., Roberts, E., Song, S., lab, M., lab, M., Mostafavi, S., Sasse, A., Spiro, A., lab, P. A. V., Pennacchio, L. A., Kato, M., Kosicki, M., Mannion, B., Slaven, N., Visel, A., lab, P., Pollard, K. S., Drusinsky, S., Whalen, S., lab, R., Ray, J., Harten, I. A., Ho, C.-H., lab, R., lab, S., Sanjana, N. E., Caragine, C., Morris, J. A., lab, S., Seruggia, D., Kutschat, A. P., Wittibschlager, S., lab, X., Xu, H., Fu, R., He, W., Zhang, L., lab, Y., Osorio, D., name), N. P. M. (. B. L., Bly, Z., Calluori, S., Gilchrist, D. A., Hutter, C. M., Morris, S. A., & Samer, E. K.
- Venue
- Nature
- Published
- 2024-09-04
- Volume
- 633
- Issue
- 8028
- Pages
- 47-57
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W4402220283
- Cited by
- 88
- References
- 90
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.